Cubist Systematic Strategies’s Aratana Therapeutics, Inc. PETX Stock Holding History

Cubist Systematic Strategies’s Portfolio PETX Stock Details PETX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	–	Sell	-45,565	Closed	-$235K	–	2668
2019 Q2	$235K	Buy	45,565 +23,665	+108%	+$106K	﹤0.01%	1967
2019 Q1	$79K	Sell	21,900 -3,700	-14%	-$16K	﹤0.01%	2041
2018 Q4	$157K	Buy	+25,600	New	+$156K	0.01%	1619
2018 Q1	–	Sell	-10,503	Closed	-$55K	–	2195
2017 Q4	$55K	Buy	+10,503	New	+$64.3K	﹤0.01%	1770
2016 Q4	–	Sell	-14,802	Closed	-$139K	–	1986
2016 Q3	$139K	Buy	+14,802	New	+$123K	0.01%	1395
2015 Q3	–	Sell	-11,922	Closed	-$180K	–	2111
2015 Q2	$180K	Buy	+11,922	New	+$172K	0.01%	1476

Other funds holding PETX

Davenport & Co Richmond, Virginia $20.4B AUM 18.11% 1-Year Est. Return

ASN

Advisory Services Network Atlanta, Georgia $7.52B AUM 29.01% 1-Year Est. Return

Cubist Systematic Strategies's PETX Position: Q3 2019 in Review

Cubist Systematic Strategies sold out of Aratana Therapeutics, Inc. (PETX) in Q3 2019, closing a stake of 45,565 shares — an estimated $235K sold.

Cubist Systematic Strategies first reported a position in PETX in Q2 2015 and held it in 6 quarters. The position peaked at $235K in Q2 2019. 2 funds tracked by Wall St. Rank hold PETX as of Q3 2019.

Cubist Systematic Strategies reported no remaining Aratana Therapeutics, Inc. position as of Q3 2019 after selling out during the quarter.
Cubist Systematic Strategies sold 45,565 Aratana Therapeutics, Inc. shares in Q3 2019, an estimated $235K.
Cubist Systematic Strategies first reported a position in Aratana Therapeutics, Inc. in Q2 2015 and held it in 6 quarters.
Cubist Systematic Strategies's Aratana Therapeutics, Inc. position peaked at $235K in Q2 2019.
2 funds tracked by Wall St. Rank held Aratana Therapeutics, Inc. as of Q3 2019.

Based on Cubist Systematic Strategies's 13F filing for Q3 2019, filed 14 Nov 2019.